ArticleJournal of translational medicine2025

Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer.

Jee Young Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.